Advertisement

Metabolic and Cardiovascular Implications of Switching From TDF to TAF-Containing Art

Metabolic and Cardiovascular Implications of Switching From TDF to TAF-Containing Art Jason Schafer, PharmD, MPH, BCPS AQ-ID, associate professor in the Department of Pharmacy Practice at Jefferson College of Pharmacy at Thomas Jefferson University, discusses the implications of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF)-containing antiretroviral therapy.

TAF-Containing

Post a Comment

0 Comments